Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer.
Baylot, Virginie
Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer. [electronic resource] - Molecular therapy : the journal of the American Society of Gene Therapy Dec 2012 - 2244-56 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1525-0024
10.1038/mt.2012.155 doi
Animals
Antineoplastic Agents--therapeutic use
Biomarkers, Tumor--genetics
Blotting, Western
Castration
Cell Line, Tumor
Docetaxel
Flow Cytometry
Fluorescent Antibody Technique
HSP27 Heat-Shock Proteins--metabolism
Humans
Immunoprecipitation
Male
Mice
Mice, Nude
Prostatic Neoplasms--drug therapy
Taxoids--therapeutic use
Tumor Protein, Translationally-Controlled 1
Two-Hybrid System Techniques
Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer. [electronic resource] - Molecular therapy : the journal of the American Society of Gene Therapy Dec 2012 - 2244-56 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1525-0024
10.1038/mt.2012.155 doi
Animals
Antineoplastic Agents--therapeutic use
Biomarkers, Tumor--genetics
Blotting, Western
Castration
Cell Line, Tumor
Docetaxel
Flow Cytometry
Fluorescent Antibody Technique
HSP27 Heat-Shock Proteins--metabolism
Humans
Immunoprecipitation
Male
Mice
Mice, Nude
Prostatic Neoplasms--drug therapy
Taxoids--therapeutic use
Tumor Protein, Translationally-Controlled 1
Two-Hybrid System Techniques